Numerous studies have reported a dysregulation of NF-κB signaling in patients suffering from irritable bowel syndrome [41,42,43] and identified this pathway as one of the major regulatory components in the complex pathogenesis and progression of chronic intestinal inflammatory disorders like Crohn’s disease and ulcerative colitis [44,45]. Here, NFKB1 is linked to Crohn disease.